Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2021 / Cilt: 55 - Sayı: 1

Successful treatment of Mycobacterium chelonae skin infection in a patient on long-term immunosuppressive therapy for myasthenia gravis

Pages
51–53
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

İMREN, I. G., NALBANT, E. K., KARAOSMANOĞLU, N., KUTLU, Ö., TURAN, Ç., ÇELEPLİ, P., EKŞİOĞLU, H. (2021). Successful treatment of Mycobacterium chelonae skin infection in a patient on long-term immunosuppressive therapy for myasthenia gravis. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 55 - Sayı: 1, 51–53. https://ajindex.com/articles/414077

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Pinto-Gouveia M, Gameiro A, Ramos L, et al: Mycobacterium chelonae is an ubiquitous atypical mycobacterium. Case Rep Dermatol 2015;7:207-11
  2. Samaddar A, Srivastava S, Khan S, et al: Mycobacterium chelonae bacteraemia in a patient with myasthenia gravis receiving long-term steroid therapy. Access Microbiol 2019;1:e000069
  3. Chat VS, Kearns DG, Uppal SK, Wu JJ: Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy. J Dermatolog Treat 2019-12:1-2
  4. McCallum C, Johnson B: Mycobacterium chelonae bacteremia in a patient taking infliximab and prednisone. CMAJ 2016;188:E538
  5. Lee WJ, Kang SM, Sung H,et al: Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases. J Dermatol 2010;37:965-72
  6. Ulusoy E, Karaca NE, Aksu G, Çavuşoğlu C, Kütükçüler N: Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies. Turk Pediatri Ars 2017;52:138-44.